313 related articles for article (PubMed ID: 29751879)
1. Hepatic Adenomas: Classification, Controversies, and Consensus.
Torbenson M
Surg Pathol Clin; 2018 Jun; 11(2):351-366. PubMed ID: 29751879
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
3. Genetics and imaging of hepatocellular adenomas: 2011 update.
Katabathina VS; Menias CO; Shanbhogue AK; Jagirdar J; Paspulati RM; Prasad SR
Radiographics; 2011 Oct; 31(6):1529-43. PubMed ID: 21997980
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
5. Genotype phenotype classification of hepatocellular adenoma.
Bioulac-Sage P; Blanc JF; Rebouissou S; Balabaud C; Zucman-Rossi J
World J Gastroenterol; 2007 May; 13(19):2649-54. PubMed ID: 17569132
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
9. [Malignant transformation of multiple isolated hepatocellular adenomas. Therapeutic implications of immunohistochemical and radiological findings].
Baulieux J; Manichon AF; Bancel B; D'Errico E; Raspado O; Ducerf C; Mabrut JY; Rode A
Bull Acad Natl Med; 2012 Feb; 196(2):459-81; discussion 482-3. PubMed ID: 23420963
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
11. Molecular classification of hepatocellular adenoma in clinical practice.
Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Adenomas in Patients 60 and Older Are Enriched for HNF1A Inactivation and Malignant Transformation.
Yasir S; Chen ZE; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson MS
Am J Surg Pathol; 2022 Jun; 46(6):786-792. PubMed ID: 35383587
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
15. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics.
Dhingra S; Fiel MI
Arch Pathol Lab Med; 2014 Aug; 138(8):1090-7. PubMed ID: 25076298
[TBL] [Abstract][Full Text] [Related]
16. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular adenomas: review of pathological and molecular features.
Beaufrère A; Paradis V
Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
[TBL] [Abstract][Full Text] [Related]
18. [Hepatocellular carcinoma in an inflammatory adenoma with β-catenin mutation in a patient with hepatocellular adenomatosis due to germline mutation in HNF1α].
Ridder DA; Duret D; Wörns MA; Schotten S; Heinrich S; Kloth M; Springer E; Roth W; Straub BK
Z Gastroenterol; 2019 Jan; 57(1):46-51. PubMed ID: 30641602
[TBL] [Abstract][Full Text] [Related]
19. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
20. Pigmented hepatocellular adenomas have a high risk of atypia and malignancy.
Mounajjed T; Yasir S; Aleff PA; Torbenson MS
Mod Pathol; 2015 Sep; 28(9):1265-74. PubMed ID: 26205181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]